These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9767429)

  • 1. Intranasal administration of human immunodeficiency virus type-1 (HIV-1) DNA vaccine with interleukin-2 expression plasmid enhances cell-mediated immunity against HIV-1.
    Xin KQ; Hamajima K; Sasaki S; Honsho A; Tsuji T; Ishii N; Cao XR; Lu Y; Fukushima J; Shapshak P; Kawamoto S; Okuda K
    Immunology; 1998 Jul; 94(3):438-44. PubMed ID: 9767429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine.
    Xin KQ; Hamajima K; Sasaki S; Tsuji T; Watabe S; Okada E; Okuda K
    Vaccine; 1999 Feb; 17(7-8):858-66. PubMed ID: 10067692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens.
    Okada E; Sasaki S; Ishii N; Aoki I; Yasuda T; Nishioka K; Fukushima J; Miyazaki J; Wahren B; Okuda K
    J Immunol; 1997 Oct; 159(7):3638-47. PubMed ID: 9317164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice.
    Moore AC; Kong WP; Chakrabarti BK; Nabel GJ
    J Virol; 2002 Jan; 76(1):243-50. PubMed ID: 11739689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes.
    Sasaki S; Sumino K; Hamajima K; Fukushima J; Ishii N; Kawamoto S; Mohri H; Kensil CR; Okuda K
    J Virol; 1998 Jun; 72(6):4931-9. PubMed ID: 9573261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage inflammatory protein-1alpha (MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1.
    Lu Y; Xin KQ; Hamajima K; Tsuji T; Aoki I; Yang J; Sasaki S; Fukushima J; Yoshimura T; Toda S; Okada E; Okuda K
    Clin Exp Immunol; 1999 Feb; 115(2):335-41. PubMed ID: 9933462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of RANTES expression plasmid with a DNA vaccine enhances HIV-1-specific immunity.
    Xin KQ; Lu Y; Hamajima K; Fukushima J; Yang J; Inamura K; Okuda K
    Clin Immunol; 1999 Jul; 92(1):90-6. PubMed ID: 10413656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses.
    Santana VC; Almeida RR; Ribeiro SP; Ferreira LC; Kalil J; Rosa DS; Cunha-Neto E
    Mem Inst Oswaldo Cruz; 2015 Dec; 110(8):1010-6. PubMed ID: 26602876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal administration of HIV-DNA vaccine formulated with a polymer, carboxymethylcellulose, augments mucosal antibody production and cell-mediated immune response.
    Hamajima K; Sasaki S; Fukushima J; Kaneko T; Xin KQ; Kudoh I; Okuda K
    Clin Immunol Immunopathol; 1998 Aug; 88(2):205-10. PubMed ID: 9714699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration.
    Barouch DH; Santra S; Steenbeke TD; Zheng XX; Perry HC; Davies ME; Freed DC; Craiu A; Strom TB; Shiver JW; Letvin NL
    J Immunol; 1998 Aug; 161(4):1875-82. PubMed ID: 9712056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in T helper 1-related immune responses in BALB/c mice immunized with an HIV-1 gag plasmid combined with a chimeric plasmid encoding interleukin-18 and flagellin.
    Chen YL; Chen YS; Hung YC; Liu PJ; Tasi HY; Ni WF; Hseuh PT; Lin HH
    Microbiol Immunol; 2015 Aug; 59(8):483-94. PubMed ID: 26094825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen.
    Tsuji T; Hamajima K; Ishii N; Aoki I; Fukushima J; Xin KQ; Kawamoto S; Sasaki S; Matsunaga K; Ishigatsubo Y; Tani K; Okubo T; Okuda K
    Eur J Immunol; 1997 Mar; 27(3):782-7. PubMed ID: 9079822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 8 Br-cAMP enhances both humoral and cell-mediated immune responses induced by an HIV-1 DNA vaccine.
    Arai H; Xin KQ; Hamajima K; Lu Y; Watabe S; Takahashi T; Toda S; Okuda K; Kudoh I; Suzuki M; Okuda K
    Gene Ther; 2000 Apr; 7(8):694-702. PubMed ID: 10800093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses.
    Bråve A; Hallengärd D; Schröder U; Blomberg P; Wahren B; Hinkula J
    Vaccine; 2008 Sep; 26(40):5075-8. PubMed ID: 18450334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses.
    Sun X; Zhang H; Xu S; Shi L; Dong J; Gao D; Chen Y; Feng H
    Virol J; 2017 Aug; 14(1):163. PubMed ID: 28830557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses against a new HIV-1 p24-gp41/pCAGGS-IL-12 DNA vaccine in Balb/c mice.
    Roodbari F; Sabahi F; Sarbolouki MN; Barkhordari F; Adeli A; Jamedar A; Mahboudi F
    Iran J Immunol; 2012 Jun; 9(2):86-97. PubMed ID: 22735796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity, after nasal application of HIV-1 DNA gagp37 plasmid vaccine in young mice.
    Hinkula J; Hagbom M; Wahren B; Schroder U
    Vaccine; 2008 Sep; 26(40):5101-6. PubMed ID: 18482783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
    Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
    Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zymosan enhances the immune response to DNA vaccine for human immunodeficiency virus type-1 through the activation of complement system.
    Ara Y; Saito T; Takagi T; Hagiwara E; Miyagi Y; Sugiyama M; Kawamoto S; Ishii N; Yoshida T; Hanashi D; Koshino T; Okada H; Okuda K
    Immunology; 2001 May; 103(1):98-105. PubMed ID: 11380697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid DNA Vaccine Co-Immunisation Modulates Cellular and Humoral Immune Responses Induced by Intranasal Inoculation in Mice.
    King DF; McKay PF; Mann JF; Jones CB; Shattock RJ
    PLoS One; 2015; 10(11):e0141557. PubMed ID: 26544970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.